$CATS: Big Upside Runner



-Lowfloat (float less than 3mln shares)
-Huge potential application for insurance market.
-Recent Nasdaq Listing(Not much press coverage)
-Conference to be held at the Mandarin Oriental Hotel in New York City on Tuesday, May 2, 2017 at 10:00 am ET by Terren Peizer, Chairman of the Board and Chief Executive Officer.
 

Catasys, Inc. (CATS) provides data analytics based specialized behavioral health management and integrated treatment services to health plans through our On Trak solution. Our On Trak  solution is designed to improve member health and at the same time lower costs to the insurer for underserved populations where behavioral health conditions are causing or exacerbating co-existing medical conditions. The program utilizes proprietary analytics, member engagement and patient centric treatment that integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient program. Our initial focus was members with substance use disorders, but we have expanded our solution to assist members with anxiety and depression. We currently operate our On Trak solutions in Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. We provide services to commercial (employer funded), managed Medicare Advantage, and managed Medicaid and duel eligible (Medicare and Medicaid) populations.

 

 

 

 

 

 


Business strategy is to provide a quality integrated medical and behavioral program to help health plans and other organizations treat and manage health plan members whose behavioral health conditions are exacerbating co-existing medical conditions resulting in increased in-patient medical costs. Our initial focus was members with substance use disorder, and we have expanded our solution into anxiety disorders and depression.
 
Key elements of company business strategy include :
 


  Demonstrating the potential for improved clinical outcomes and reduced cost associated with using our On Trak solution with key managed care and other third-party payors;
 


  Educating third-party payors on the disproportionately high cost of their substance dependent population;
 


  Providing our On Trak solution to third-party payors for reimbursement on a case rate, fee for service, or monthly fee basis; 
 


  Generating outcomes data from our On Trak solution to demonstrate cost reductions and utilization of this outcomes data to facilitate broader adoption.
 
As an early entrant into offering integrated medical and behavioral programs for substance dependence, we believe we will be well positioned to address increasing market demand. We believe our On Trak solution will help fill the gap that exists today: a lack of programs that focus on smaller populations with disproportionately higher costs driven by behavioral health conditions that improve patient care while controlling overall treatment costs.

Company provide data analytics based specialized behavioral health management and integrated treatment services to health plans through our On Trak solution. Our On Trak  solution is designed to improve member health and at the same time lower costs to the insurer for underserved populations where behavioral health conditions are causing or exacerbating co-existing medical conditions. The program utilizes proprietary analytics, member engagement and patient centric treatment that integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient program. Our initial focus was members with substance use disorders, but we have expanded our solution to assist members with anxiety and depression. We currently operate our On Trak solutions in Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin. We provide services to commercial (employer funded), managed Medicare Advantage, and managed Medicaid and duel eligible (Medicare and Medicaid) populations. 

Our Market
 
The true impact of behavioral health is often under-identified by organizations that provide healthcare benefits. The reality is that individuals with behavioral health conditions:
 


 
are prevalent in any organization;
 


 
cost health plans and employers a disproportionate amount of money;
 


 
have higher rates of absenteeism and lower rates of productivity; and
 


 
have co-morbid medical conditions which incur increased costs for the treatment of these conditions compared to a non-substance dependent population.
 
When considering behavioral health-related costs, many organizations have historically only looked at direct treatment costs–usually behavioral claims.  The reality is that individuals with behavioral health conditions generally have overall poorer health and lower compliance, which leads to more expensive treatment for related, and even seemingly unrelated, co-occurring medical conditions. In fact, for the members we seek to engage our solutions, costs associated with behavioral health treatment are a small portion of their overall healthcare claims.
 
According to the U.S. Census Bureau in 2014, there were over 283 million lives in the U.S. covered by various private managed care programs, including Preferred Provider Organizations (PPOs), Health Maintenance Organizations (HMOs), self-insured employers and managed Medicare/Medicaid programs.  Each year, based on our analysis, approximately 1.9% of commercial plan members will have a substance dependence diagnosis, and that figure may be lesser or greater for specific payors depending on the health plan demographics and location.  A smaller, high-cost subset of this population drives the majority of the claims costs for the overall substance dependent population.  For commercial members with substance dependence and a total annual claims cost of at least $7,500, the average annual per member claims cost is $30,000, compared with an average of $3,250 for a commercial non-substance dependent member, according to our research.  
 
Our Customers
 
Our customers provide health insurance to individuals or groups (Contracted Membership). We contract with our customers to provide our On Trak solution to the customers’ Contracted Membership generally in specific lines of business (e.g., commercial, Medicare, Medicaid, etc.) and/or specific states or other geographical areas and for specific indications, such as substance use disorders and, more recently, anxiety and depression. We refer to the Contracted Membership to whom we are providing the On Trak solution as Covered Lives. Generally, we receive data relating to the Covered Lives on a regular basis from our customers. We use that data to identify members who meet our contractual eligibility requirements (Eligible Members) and we attempt to engage and enroll those members in our On Trak solution. Our Eligible Members can fluctuate significantly from month to month due to fluctuations in our customers’ Contracted Membership and changes in eligibility due to changes in claims or eligibility data provided to us by our customers. Based on our analysis of the data provided to us by our customers, approximately 0.45% of the adult Contracted Membership in a commercial line of business is anticipated to be eligible for our On Trak solution. Based on our analysis, Medicare and Medicaid lines of business average approximately 2.5 times the number of Eligible Members for our On Trak solution as the same number of Covered Lives in a commercial line of business. Further, our preliminary data analysis shows that adding anxiety and depression indications to our Covered Lives is anticipated to increase our pool of Eligible Members substantially. Based on the latest data provided by one of our customers that has contracted for us to provide On Trak for anxiety, adding the anxiety and depression indications are anticipated to increase the number of Eligible Members by approximately four times over substance use disorders alone. There are fluctuations in the number of Eligible Members across customers and geographies. Our analysis to date is based on limited data, and in some cases like anxiety and depression, very limited data. There can be no assurance that the data we have analyzed to date will be predictive of the future or that the portion of Covered Lives that are eligible for our programs will not change in the future. In addition, the percentage of Eligible Members in any lines of Covered Lives may fluctuate substantially from period to period.



 

Catasys, Inc. ($CATS) Solution: On Trak

 
On Trak
 
Our On Trak solution combines evidence-based medical and psychosocial treatments with elements of population health management and ongoing member support to help health plans treat members with substance dependence, anxiety and depression and to improve member health and lower the overall health plan costs of these members. We believe the benefits of our On Trak solution include improved clinical outcomes and decreased costs for the payor, and improved quality of life and productivity for the member.
 
Although the healthcare services industry is competitive, we believe On Trak is the only solution of its kind. The On Trak solution was developed by behavioral health experts with years of clinical experience. This experience has helped to form key areas of expertise that we believe sets our solution apart from other solutions, including member engagement, working directly with the member treatment team and a more fully integrated treatment offering.
 
Our On Trak solution includes the following components: identification of impactable members, member engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and our proprietary web-based clinical information platform (eOn Trak ).
 
We assist health plans to identify those members who incur significant costs and may be appropriate for enrollment into On Trak . We then engage and enroll targeted members into our program through direct mailings and telephonic outreach, and referral through health plan sources. After enrollment, our contracted network of providers provide treatments utilizing integrated medical and psychosocial treatment modalities, including our proprietary On Trak therapy modules for anxiety, depression and substance use disorders to help members develop improved coping skills and a recovery support network. Throughout the treatment process, our care coaches work directly with members to keep them engaged in treatment by proactively supporting members to enhance motivation, minimize lapses and enable lifestyle modifications consistent with the recovery goals. Periodically, we will provide outcomes reporting on clinical and financial metrics to our customers to demonstrate the extent of the program’s value.
 
Clinical and financial outcomes from the On Trak solution have been promising with On Trak enrolled members achieving an average gross cost reduction of more than 50% for the year after enrollment compared to the 12 months prior to enrollment. In addition, to date, approximately 80% of members who have remained eligible have been retained in the program.
 

 DISCLAIMER

This report/release is a commercial advertisement and is for general information
purposes ONLY. We are engaged in the business of marketing and advertising companies
for compensation. Never invest in any stock featured on our reports/releases unless you
can afford to lose your entire investment. The track record, gains, upside or losses
are all hypothetical and should not be considered as a basis for investment.
This report/release is not a solicitation or recommendation to buy securities of the
advertised company. An offer to buy or sell securities can be made only by a disclosure
document that complies with applicable securities laws and only in the States or other
jurisdictions in which the security is eligible for sale. Reports/releases distributed
through disseminated reports/released are not disclosure documents. If you are
considering purchasing any securities of an advertised company, you should read and
review, if and to the extent available, any information concerning a marketed company
available at the web sites of the U.S. Securities and Exchange Commission (the "SEC")
at www.sec.gov;the Financial Industry Regulatory Authority (the "FINRA") at
www.FINRA.org and your State Securities Administrator. We also strongly recommend that
you read the SEC advisory to investors concerning Internet Stock Fraud at
www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA
on how to invest carefully. You are responsible for verifying all claims and conducting
your own due diligence.
You agree and acknowledge that any hyperlinks to the website of (1) a client company,
(2) the party issuing or preparing the information for the company, or (3) other
information contained in our disseminated reports/releases is provided only for your
reference and convenience. We are not responsible for the accuracy or reliability of
these external sites, nor are we responsible for the content, opinions, products or
other materials on external sites or information sources. If you use, act upon or make
decisions in reliance on information contained in any disseminated report/release or
any hyperlink, you do so at your own risk and agree to hold us, our officers,
directors, shareholders, affiliates and agents harmless. You acknowledge that you are
not relying on us, and we are not liable for, any actions taken by you based on any
information contained in any disseminated report/release or hyperlink. You also
acknowledge that we are not an investment advisory service, a broker-dealer or an
investment adviser. You acknowledge that you will consult with your own advisers
regarding any decisions as to any company mentioned herein.
We have not determined if the statements and opinions of the message are accurate,
correct or truthful. The profiles we publish are compiled from publicly available
information, which include, but are not limited to, no cost online research, magazines,
newspapers, reports filed with the SEC or information furnished by way of press
releases. Because virtually all information relied upon by us in preparing an Issuer
profile comes from a public source which has been made public directly from the Issuer,
the information is not confirmed with a second source.
The purpose of this report/release, like any promotion, is to provide publicity for the
client company, its products or services. Owners and operators of
nasdaqrunners.blogspot.com do not own any equity nor debt in companies mentioned in
this email as of 4/26/17. You should not rely on the information presented; you should
do independent research to form your own opinion and decision. Information contained in
our disseminated reports/releases does not constitute investment, legal or tax advice
upon which you should rely. The purchase of high-risk securities may result in the loss
of your entire investment. Owners and operators of nasdaqrunners.blogspot.com own
several newsletters, therefore you may receive our emails featuring companies at
different times.
You are receiving this report/release because you subscribed to received it at our
website or through a third party site.  All of our newsletters include an "unsubscribe"
link, and you can remove yourself at any time from our newsletters by clicking on that
"unsubscribe" link. You can also contact us at info@nasdaqrunners.blogspot.com to
change your information at any time.  By your subscription to our profiles, the viewing
of this profile and/or use of our website, you have agreed and acknowledged the terms
of our disclaimer.
The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor'
in regard to forward-looking statements. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs, plans, projections,
objectives, goals, assumptions or future events or performance are not statements of
historical fact may be "forward looking statements". Forward looking statements are
based on expectations, estimates, and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual results or
events to differ materially from those presently anticipated. Forward looking
statements in this action may be identified through use of words such as "projects",
"foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or
that by statements indicating certain actions & quote; "may", "could", or "might"
occur. Understand there is no guarantee past performance will be indicative of future
results.









 



Комментариев нет:

Отправить комментарий